Completed NA NCT00226096

Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage

A Randomised Trial to Establish the Effects of Early Intensive Blood Pressure Lowering on Death and Disability in Patients With Stroke Due to Acute Intracerebral Haemorrhage

Sponsor: National Health and Medical Research Council, Australia

Conditions CVA (Cerebrovascular Accident) Cerebral Hemorrhage Intracranial Hemorrhages

Interventions Clonidine Enalaprilat Esmolol Glycerol Trinitrate Hydralazine Hydrochloride Labetalol Hydrochloride Metoprolol tartrate Nicardipine Nitroprusside Phentolamine mesylate Urapidil

Updated 5 times since 2017 Last updated: Jun 25, 2008 Started: Nov 30, 2005 Primary completion: Sep 30, 2007 Completion: Sep 30, 2007

A NA clinical study on CVA (Cerebrovascular Accident) and Cerebral Hemorrhage, this trial is completed. The trial is conducted by National Health and Medical Research Council, Australia and has accumulated 5 data snapshots since 2005. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Nov 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Health and Medical Research Council, Australia
The George Institute

Data source: The George Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Adelaide, Australia , Auckland, New Zealand , Beijing, China , Christchurch, New Zealand , Concord, Australia , Gosford, Australia , Kogarah, Australia , Melbourne, Australia , Newcastle, Australia , Perth, Australia and 3 more locations